Liminatus Pharma, Inc. — All Filings
82 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-Q
3
424B3
424B4
8-K
8-K/A
8-K12B
CORRESP
DRS
EFFECT
NT 10-Q
POS AM
S-1
S-1/A
S-4
S-4/A
SCHEDULE 13D
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001104659-26-023467 | Mar 4, 2026 | Feb 27, 2026 |
| SCHEDULE 13G | — | 0001213900-26-018820 | Feb 20, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-017134 | Feb 18, 2026 | Feb 17, 2026 |
| 424B4 | 424B4 | 0001104659-26-016706 | Feb 18, 2026 | — |
| EFFECT | — | 9999999995-26-000587 | Feb 13, 2026 | — |
| S-1 | S-1 | 0001104659-26-012942 | Feb 11, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-012016 | Feb 9, 2026 | Feb 6, 2026 |
| 8-K | FORM 8-K | 0001104659-26-006619 | Jan 26, 2026 | Jan 15, 2026 |
| DRS | — | 0001104659-25-125670 | Dec 31, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-116049 | Nov 25, 2025 | Nov 19, 2025 |
| 10-Q | 10-Q | 0001104659-25-111651 | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001104659-25-096872 | Oct 6, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001104659-25-082579 | Aug 25, 2025 | Aug 22, 2025 |
| 3 | PRIMARY DOCUMENT | 0001200876-25-000042 | Aug 15, 2025 | Apr 30, 2025 |
| NT 10-Q | NT 10-Q | 0001104659-25-078852 | Aug 15, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001104659-25-078577 | Aug 14, 2025 | — |
| 424B3 | 424B3 | 0001410578-25-001746 | Aug 13, 2025 | — |
| EFFECT | — | 9999999995-25-002576 | Aug 12, 2025 | — |
| CORRESP | — | 0001104659-25-076067 | Aug 11, 2025 | — |
| S-1/A | S-1/A | 0001410578-25-001518 | Jul 28, 2025 | — |
| CORRESP | — | 0001104659-25-070940 | Jul 25, 2025 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-069941 | Jul 23, 2025 | Jul 10, 2025 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-069332 | Jul 21, 2025 | Jul 10, 2025 |
| 8-K | FORM 8-K | 0001104659-25-068670 | Jul 17, 2025 | Jul 16, 2025 |
| 8-K | FORM 8-K | 0001104659-25-067444 | Jul 11, 2025 | Jul 10, 2025 |
| UPLOAD | — | 0000000000-25-007061 | Jul 3, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-065663 | Jul 3, 2025 | Jul 2, 2025 |
| SCHEDULE 13G | — | 0000950170-25-091130 | Jun 27, 2025 | — |
| 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-012207 | Jun 27, 2025 | Apr 30, 2025 |
| SCHEDULE 13G | — | 0001104659-25-063104 | Jun 26, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-063100 | Jun 26, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-063098 | Jun 26, 2025 | — |
| S-1 | S-1 | 0001410578-25-001432 | Jun 24, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-062058 | Jun 24, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-061875 | Jun 24, 2025 | Jun 23, 2025 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-060002 | Jun 16, 2025 | Apr 30, 2025 |
| 8-K | FORM 8-K | 0001104659-25-056421 | Jun 4, 2025 | May 29, 2025 |
| 10-Q | 10-Q | 0001410578-25-001388 | Jun 2, 2025 | Mar 31, 2025 |
| 8-K/A | FORM 8-K/A | 0001104659-25-055078 | Jun 2, 2025 | Apr 30, 2025 |
| NT 10-Q | NT 10-Q | 0001104659-25-049500 | May 15, 2025 | Mar 31, 2025 |
| SCHEDULE 13D | — | 0001200876-25-000020 | May 8, 2025 | — |
| SCHEDULE 13D | — | 0001104659-25-045628 | May 7, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-045127 | May 6, 2025 | Apr 30, 2025 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-042845 | May 1, 2025 | Apr 30, 2025 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-042835 | Apr 30, 2025 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-042793 | Apr 30, 2025 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-042791 | Apr 30, 2025 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-042790 | Apr 30, 2025 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-042767 | Apr 30, 2025 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-042764 | Apr 30, 2025 | — |